Craig-Hallum initiated coverage of Veracyte (VCYT) with a Buy rating and $45 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VCYT:
- Veracyte’s Strong Market Position and Growth Potential Drive Buy Rating
- Veracyte Inc. Reports Strong 2024 Earnings Amid Challenges
- Veracyte’s Strong Q4 2024 Performance and Strategic Moves Justify Buy Rating
- Veracyte Inc. Reports Strong 2024 Financial Performance
- Veracyte sees FY25 testing revenue $470M-$480M